Related Experiment Video
Updated: Jun 16, 2025
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
Targeted therapy for leukemia based on nanomaterials
Suying Qian1, Cuiping Zheng2, Yanfang Wu3
1Department of Hematology and Oncology, Ningbo No.2 Hospital, Ningbo, 315000, China.
Abstract:
Leukemia is a kind of hematopoietic stem cell malignant clonal disease. Drug therapy is the core treatment strategy for leukemia, but the current therapeutic drugs have defects such as low bioavailability, large adverse reactions and inconvenient intravenous administration. Targeted therapy can combine drugs with specific carcinogenic sites on cells to kill cancer cells and avoid damage to normal cells, which has gradually become the mainstream method of leukemia treatment. In addition, nanomedicine delivery systems can significantly improve drug efficacy through controlled size and targeted optimization of drug delivery by modification strategies. Therefore, the targeted treatment of leukemia based on nanomaterials has great research value and application prospect. This paper gives an overview of the current therapeutic strategies for leukemia, and then reviews the cutting-edge targeted therapeutic nanomaterials for leukemia, including organic nanomaterials (mainly carbon-based nanomaterials, lipid materials, polymers, etc.) and inorganic nanomaterials (mainly noble metal nanoparticles, magnetic nanoparticles, hollow mesoporous materials, etc.). The challenges and prospects for the future development of targeted nanomaterials in the treatment of leukemia are also briefly reviewed.
Insights
Targeted nanomaterials offer promising leukemia treatment by improving drug delivery and reducing side effects. This review explores advanced organic and inorganic nanomaterials for enhanced leukemia therapy.
Area of Science:
- Oncology
- Nanomedicine
- Biomedical Engineering
Background:
- Leukemia is a malignant hematopoietic stem cell disease with limitations in current drug therapies, including poor bioavailability and significant adverse effects.
- Targeted therapy is emerging as a mainstream treatment, aiming to selectively eliminate cancer cells while sparing healthy ones.
- Nanomedicine delivery systems enhance drug efficacy through controlled release and targeted delivery, showing great potential for leukemia treatment.
Purpose of the Study:
- To provide an overview of current leukemia therapeutic strategies.
- To review cutting-edge targeted therapeutic nanomaterials for leukemia treatment.
- To discuss the challenges and future prospects of nanomaterials in leukemia therapy.
Main Methods:
- Review of current literature on leukemia treatment strategies.
- Categorization and discussion of organic nanomaterials (carbon-based, lipid, polymers).
- Categorization and discussion of inorganic nanomaterials (noble metal nanoparticles, magnetic nanoparticles, hollow mesoporous materials).
Main Results:
- Current drug therapies for leukemia face challenges with bioavailability, adverse reactions, and administration.
- Targeted therapy and nanomedicine delivery systems show significant promise for improving leukemia treatment outcomes.
- Both organic and inorganic nanomaterials are being explored for their potential in targeted leukemia therapy.
Conclusions:
- Nanomaterials offer a promising avenue for developing more effective and safer targeted therapies for leukemia.
- Further research into the challenges and prospects of these nanomaterials is crucial for clinical translation.
- Targeted nanomaterial-based strategies hold significant research value and application potential for leukemia treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...